RMRamesh Mullangi

Ramesh Mullangi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ramesh Mullangi has a total of 61 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Sensitive LC-MS/MS Method for the Simultaneous Determination of Bendamustine and its Active Metabolite, γ-Hydroxybendamustine in Small Volume Mice and Dog Plasma and its Application to a Pharmacokinetic Study in Mice and Dogs

    by Devaraj V. Chandrashekar, Ponnayyan S Suresh, Rajnish Kumar, Ravi Kanth Bhamidipati, Ramesh Mullangi, Wolfgang Richter, Nuggehally R Srinivas

    A highly sensitive, specific and rapid LC-ESI-MS/MS method has been developed and validated for the simultaneous quantification of bendamustine (BM) and γ-hydroxybendamustine (HBM) in small volume (20 µL) mice and dog plasma using phenacetin as an internal standard (IS) as per regulatory guidelines. Both the analytes and IS were extracted from mice and dog plasma using a liquid-liquid extraction method. Chromatography was achieved on Atlantis dC18 column using an isocratic mobile phase (0.2% formic acid:acetonitrile, 25:75) at a flow rate of 0.40 mL/min. The total chromatographic run time was 3.0 min and the elution of BM, HBM and IS occurred at ~1.2, 1.2 and 2.0 min, respectively. A linear response function was established 0.11–518 ng/mL for both the analytes in mice and dog plasma. The intra- and inter-day accuracy and precisions were in the range of 3.46–12.9 and 3.63–8.23%; 1.15–9.00 and 7.86–9.49% for BM and HBM, respectively in mice plasma and 2.15–6.49 and 1.73–13.1%; 4.35–13.9 and 4.33–10.5% for BM and HBM, respectively in dog plasma. This novel method has been applied to a pharmacokinetic study in mice and dogs.


  • Species difference in the in vitro and in vivo metabolism of amtolmetin guacil

    by Kishore Kumar Hotha, Vijaya Bharathi Dasari, Abdul Naveed Shaik, Muzeeb Syed, Vittal Shivva, Ravindranath Krishnarao Lakshmanarao, Jayaveera Narasimhulu Korlakunta, Ramesh Mullangi

    Tolmetin (TMT, CAS 26171-23-3) is a non-steroidal anti-inflammatory drug (NSAID) indicated for the relief of signs and symptoms of osteoarthritis, rheumatoid arthritis and juvenile rheumatoid arthritis. As TMT causes gastro-intestinal side effects like other NSAIDs, its non-acidic prodrug amtolmetin guacil (AMG, CAS 87344-06-7) was synthesized. AMG has similar NSAID properties like TMT with additional gastroprotective property. The aim of this study was to investigate whether TMT and AMG are differentially metabolised in rat and human plasma (fresh and acidified) and liver microsomes. TMT was found to be stable in all the matrices tested viz., rat and human plasma (fresh and acidified) and liver microsomes. AMG was found to be stable only in acidified rat and human plasma. On the contrary, in fresh human plasma and human liver microsomes AMG was rapidly converted to two metabolites, which were subsequently identified as MED5 and MED5 methyl ester, without yielding any intact TMT. However, in rat fresh plasma and liver microsomes, AMG formed MED5 (predominant) and TMT. To corroborate the in vitro findings, in vivo pharmacokinetics (PK) studies were done following separate dosing of AMG in both rats and humans. In rats, the PK data substantiated that following oral administration of AMG it will be converted to TMT resulting in similar PK parameters observed for TMT when it was administered alone. In humans, however, AMG yields low levels of TMT which substantes the in vitro results. Levels of AMG were not detectable in the plasma. These results confirm the species differences in the in vitro and in vivo metabolism and disposition of AMG. More research work to further explore and understand AMG metabolism in humans is required.


  • Development and validation of a highly sensitive and robust LC‐ESI‐MS/MS method for simultaneous quantitation of simvastatin acid, amlodipine and valsartan in human plasma: application to a clinical pharmacokinetic study

    by Addepalli V. Ramani, Pinaki Sengupta, Ramesh Mullangi

    A high‐throughput, simple, highly sensitive and specific LC‐MS/MS method has been developed for simultaneous estimation of simvastatin acid (SA), amlodipine (AD) and valsartan (VS) with 500 µL of human plasma using deuterated simvastatin acid as an internal standard (IS). The API‐4000 LC‐MS/MS was operated under the multiple reaction‐monitoring mode (MRM) using electrospray ionization. The assay procedure involved precipitation of SA, AD, VS and IS from plasma with acetonitrile. The total run time was 2.8 min and the elution of SA, AD, VS and IS occurred at 1.81, 1.12, 1.14 and 1.81 min, respectively; this was achieved with a mobile phase consisting of 0.02 m ammonium formate (pH 4.5):acetonitrile (20:80, v/v) at a flow rate of 0.50 mL/min on an X‐Terra C18 column. A linear response function was established for the range of concentrations 0.5–50 ng/mL (r > 0.994) for VS and 0.2–50 ng/mL (r > 0.996) for SA and AD. The method validation parameters for all three analytes met the acceptance as per FDA guidelines. This novel method has been applied to human pharmacokinetic study. Copyright © 2009 John Wiley & Sons, Ltd.


  • Highly sensitive method for the determination of omeprazole in human plasma by liquid chromatography–electrospray ionization tandem mass spectrometry: application to a clinical pharmacokinetic study

    by Shivva Vittal, Ramesh Ganneboina, Buddhadev Layek, Ravi Kumar Trivedi, Kishore Kumar Hotha, D. Vijaya Bharathi, Ramesh Mullangi

    A highly sensitive, rapid assay method has been developed and validated for the estimation of omeprazole (OPZ) in human plasma with liquid chromatography coupled to tandem mass spectrometry with electrospray ionization in the positive‐ion mode. The assay procedure involves alkalinization of plasma followed by simple liquid–liquid extraction of OPZ and lansoprazole (internal standard, IS) from human plasma with acetonitrile. Chromatographic separation was achieved with 0.01 m ammonium acetate:acetonitrile (40:60, v/v) at a flow rate of 0.25 mL/min on an Inertsil ODS 3 column with a total run time 2.5 min. The MS/MS ion transitions monitored were 346.1 → 198.1 for OPZ and 370.1 → 252.1 for IS. Method validation and clinical sample analysis were performed as per FDA guidelines and the results met the acceptance criteria. The lower limit of quantitation achieved was 0.05 ng/mL and the linearity was observed from 0.05 to 10.0 ng/mL. The intra‐day and inter‐day precisions were in the ranges 2.09–8.56 and 5.29–8.19%, respectively. This novel method has been applied to a pharmacokinetic study of OPZ in humans. Copyright © 2008 John Wiley & Sons, Ltd.


  • Assessing the issue of instability due to Michael adduct formation in novel chemical entities possessing a carbon–carbon double bond during early drug development— applicability of common laboratory analytical protocols

    by Akshanth Reddy Polepally, Venkata V. Pavan Kumar, Ravikanth Bhamidipati, Jagannath Kota, Shaik Abdul Naveed, Karnati Harinder Reddy, Rao N.V.S. Mamidi, N. Selvakumar, Ramesh Mullangi, Nuggehally R. Srinivas

    The discovery of small‐molecule novel chemical entities (NCEs) is often a complex play between appropriate structural requirements and optimization of the desired efficacy, safety and pharmacokinetic properties. One of the typical structural variants such as having an active carbon–carbon double bond (α, β‐unsaturated carbonyl group) in xenobiotics may lead to stability issues. Such functionalities are extremely reactive, paving way to nucleophilic attack by endogenously occurring and ubiquitous nucleophiles like thiols. While it is easy to make a unilateral decision to not pursue the development of xenobiotics with such functionalities, we question the wisdom of such a decision. In this report, we present in vitro methodologies with appropriate examples to illustrate the ease of assessing the reactivity of the xenobiotics containing double bonds with a known nucleophile. The protocols involve simple reaction procedures followed by measurements using standard laboratory equipments (UV spectrophotometer, HPLC and LC‐MS). Our data suggests that not all xenobiotics with carbon–carbon double bonds readily form a Michael's adduct product with glutathione. Hence, the criterion for dropping discovery compounds because of α,β‐unsaturated double bonds needs to be reconsidered. Copyright © 2008 John Wiley & Sons, Ltd.


  • Development and validation of a HPLC method for simultaneous quantitation of gatifloxacin, sparfloxacin and moxifloxacin using levofloxacin as internal standard in human plasma: application to a clinical pharmacokinetic study

    by Nimmagadda Srinivas, Lakshmi Narasu, B. Prabha Shankar, Ramesh Mullangi

    A highly selective, sensitive and accurate HPLC method has been developed and validated for the estimation of three fluoroquinolones (FQs) viz., gatifloxacin (GFC), sparfloxacin (SFC) and moxifloxacin (MFC) with 500 µL human plasma using levofloxacin (LFC) as an internal standard (IS). The sample preparation involved simple liquid–liquid extraction of GFC, SFC, MFC and IS from human plasma with ethyl acetate. The resolution of peaks was achieved with phosphate buffer (pH 2.5)–acetonitrile (80:20, v/v) at a flow rate of 1 mL/min on a Kromasil C18 column. The total chromatographic run time was 18.0 min and the simultaneous elution of GFC, SFC, MFC and IS occurred at approximately 10.8, 12.8, 17.0 and 6.0 min, respectively. The method proved to be accurate and precise at linearity range of 100–10,000 ng/mL with a correlation coefficient (r) of ≥0.999. The limit of quantitation for each of the FQs studied was 100 ng/mL. The intra‐ and inter‐day precision and accuracy values found to be within the assay variability limits as per the FDA guidelines. The developed assay method was applied to a pharmacokinetic study in human volunteers following oral administration of 400 mg GFC tablet. Copyright © 2008 John Wiley & Sons, Ltd.


  • Development and validation of a sensitive LC‐MS/MS method with electrospray ionization for quantitation of rhein in human plasma: application to a pharmacokinetic study

    by Buddhadev Layek, T. Santosh Kumar, Ravi Kumar Trivedi, Ramesh Mullangi, Nuggehally R. Srinivas

    A highly sensitive and specific LC‐MS/MS method has been developed and validated for the estimation of rhein with 100 µL human plasma using celecoxib as an internal standard (IS). The API‐4000 Q‐Trap LC‐MS/MS was operated under multiple reaction‐monitoring mode using the electrospray ionization technique. The assay procedure involved extraction of rhein and IS from human plasma with acetonitrile, which yielded consistent recoveries of 36.01 and 65.85% for rhein and IS, respectively. The total chromatographic run time was 5.0 min and the elution of rhein and IS occurred at ∼1.60 and 3.96 min, respectively. The resolution of peaks was achieved with 0.01 m ammonium acetate (pH 6.0):acetonitrile:methanol (30:58:12, v/v) on an Inertsil ODS‐3 column. The method was proved to be accurate and precise at a linearity range of 0.005–5.00 µg/mL with a correlation coefficient (r) of ≥0.995. The lower limit of quantitation was 0.005 µg/mL. The intra‐ and inter‐day precision and accuracy values were found to be within the assay variability limits as per the FDA guidelines. Rhein was found to be stable in the battery of stability studies. The application of the assay to pre‐clinical pharmacokinetic studies confirmed the utility of the assay to derive pharmacokinetic parameters. Copyright © 2008 John Wiley & Sons, Ltd.


  • Development and validation of a sensitive LC‐MS/MS method with electrospray ionization for quantitation of zafirlukast, a selective leukotriene antagonist in human plasma: application to a clinical pharmacokinetic study

    by D. Vijaya Bharathi, A. Naidu, B. Jagadeesh, K. N. K. Maha Laxmi, P. Revathi Naga Laxmi, Pandu Ranga Reddy, Ramesh Mullangi

    A highly sensitive and specific LC‐MS/MS method has been developed and validated for the estimation of zafirlukast (ZFK) with 500 µL human plasma using valdecoxib as an internal standard (IS). The API‐4000 LC‐MS/MS was operated under multiple reaction‐monitoring mode using the electrospray ionization technique. The assay procedure involved extraction of ZFK and IS from human plasma with ethyl acetate. The resolution of peaks was achieved with 10 mm ammonium acetate (pH 6.4):acetonitrile (20:80, v/v) on a Hypersil BDS C18 column. The total chromatographic run time was 2.0 min and the elution of ZFK and IS occurred at approximately 1.11 and 1.58 min, respectively. The MS/MS ion transitions monitored were 574.2 → 462.1 for ZFK and 313.3 → 118.1 for IS. The method was proved to be accurate and precise at a linearity range of 0.15–600 ng/mL with a correlation coefficient (r) of ≥0.999. The method was rugged with 0.15 ng/mL as lower limit of quantitation. The intra‐ and inter‐day precision and accuracy values were found to be within the assay variability limits as per the FDA guidelines. The developed assay method was applied to a pharmacokinetic study in human volunteers following oral administration of 20 mg ZFK tablet. Copyright © 2008 John Wiley & Sons, Ltd.


  • Development and validation of a sensitive LC‐MS/MS method with electrospray ionization for quantitation of doxofylline in human serum: application to a clinical pharmacokinetic study

    by Nimmagadda Sreenivas, M. Lakshmi Narasu, B. Prabha Shankar, Ramesh Mullangi

    A highly sensitive and specific LC‐MS/MS method has been developed and validated for the estimation of doxofylline (DFL) with 300 µL human serum using imipramine as the internal standard (IS). The API‐3000 LC‐MS/MS was operated under multiple reaction‐monitoring mode using the electrospray ionization technique. The assay procedure involved direct precipitation of DFL and IS from human serum with acetonitrile. The resolution of peaks was achieved with formic acid (pH 2.5):acetonitrile (10:90, v/v) on an Amazon C18 column. The total chromatographic run time was 3.0 min and the elution of DFL and IS occurred at approximately 1.46 and 2.15 min, respectively. The MS/MS ion transitions monitored were 267.5 → 181.1 for DFL and 281.1 → 86.2 for IS. The method was proved to be accurate and precise at linearity range of 1.00–5000 ng/mL with a correlation coefficient (r) of ≥0.999. The method was rugged with 1.00 ng/mL as lower limit of quantitation. The intra‐ and inter‐day precision and accuracy values were found to be within the assay variability limits as per the FDA guidelines. The developed assay method was applied to a pharmacokinetic study in human volunteers following oral administration of DFL tablet. Copyright © 2008 John Wiley & Sons, Ltd.


  • Chiral bioanalysis of torcetrapib enantiomers in hamster plasma by normal-phase liquid chromatography and detection by atmospheric pressure chemical ionization tandem mass spectrometry

    by Ravi Kumar Trivedi, Buddhadev Layek, T. Santosh Kumar, Shivva Vittal, Ramesh Ganneboina, P.K. Dubey, Ramesh Mullangi, Nuggehally R. Srinivas